High-Dimensional and Spatial Analysis Reveals Immune Landscape–Dependent Progression in Cutaneous Squamous Cell Carcinoma

Author:

Ferguson Angela L.123ORCID,Sharman Ashleigh R.13ORCID,Allen Ruth O.13ORCID,Ye Thomas4ORCID,Lee Jenny H.5ORCID,Low Tsu-Hui H.67ORCID,Ch'ng Sydney678ORCID,Palme Carsten E.7ORCID,Ashford Bruce910ORCID,Ranson Marie911ORCID,Clark Jonathan R.678ORCID,Patrick Ellis412ORCID,Gupta Ruta613ORCID,Palendira Umaimainthan123ORCID

Affiliation:

1. 1Infection, Immunity and Inflammation Theme, School of Medical Sciences, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia.

2. 2Centenary Institute, The University of Sydney, Sydney, New South Wales, Australia.

3. 3Charles Perkins Centre, The University of Sydney, Sydney, Australia.

4. 4School of Mathematics and Statistics, University of Sydney, Sydney, New South Wales, Australia.

5. 5Department of Medical Oncology, Chris O'Brien Lifehouse, Sydney, New South Wales, Australia.

6. 6Central Clinical School, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia.

7. 7The Department of Head and Neck Surgery, Chris O'Brien Lifehouse, Sydney, New South Wales, Australia.

8. 8Royal Prince Alfred Institute of Academic Surgery, Sydney Local Health District, Sydney, New South Wales, Australia.

9. 9Illawarra Health and Medical Research Institute, Wollongong, New South Wales, Australia.

10. 10School of Medicine, University of Wollongong, Wollongong, New South Wales, Australia.

11. 11School of Chemistry and Molecular Bioscience, University of Wollongong, Wollongong, New South Wales, Australia.

12. 12Westmead Institute for Medical Research, The University of Sydney, Westmead, New South Wales, Australia.

13. 13Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, NSW Health Pathology, Sydney, New South Wales, Australia.

Abstract

AbstractPurpose:The tumor immune microenvironment impacts the biological behavior of the tumor, but its effect on clinical outcomes in head and neck cutaneous squamous cell carcinomas (HNcSCC) is largely unknown.Experimental Design:We compared the immune milieu of high-risk HNcSCC that never progressed to metastasis with those that metastasized using multiparameter imaging mass cytometry. The cohort included both immunosuppressed patients (IS) and patients with an absence of clinical immune-suppression (ACIS). Spatial analyses were used to identify cellular interactions that were associated with tumor behavior.Results:Nonprogressing primary HNcSCC were characterized by higher CD8+ and CD4+ T-cell responses, including numerically increased regulatory T cells. In contrast, primary lesions from HNcSCC patients who progressed were largely devoid of T cells with lower numbers of innate immune cells and increased expression of checkpoint receptors and in the metastatic lesions were characterized by an accumulation of B cells. Spatial analysis reveals multiple cellular interactions associated with nonprogressing primary tumors that were distinct in primary tumors of disease-progressing patients. Cellular regional analysis of the tumor microenvironment also shows squamous cell–enriched tumor regions associated with primary nonprogressing tumors.Conclusions:Effective responses from both CD8+ and CD4+ T cells in the tumor microenvironment are essential for immune control of primary HNcSCC. Our findings indicate that the early events that shape the immune responses in primary tumors dictate progression and disease outcomes in HNcSCC.

Funder

Sydney Catalyst

The University of Sydney

Cancer Institute NSW

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3